China Pharma subsidiary acquires Ipragliflozin patent for $9.8M in stock

CHINA PHARMA HOLDINGS, INC.

Hainan Helpson enters Technology Transfer Agreement to acquire Ipragliflozin tablet patent from Juan Zhang.
Total consideration: $9.8 million paid in 7,000,000 restricted CPHI shares at $1.40 per share.
Transferor to provide technical services including product R&D, registration materials, and application.
Shares issued under Regulation S to non-U.S. person, unregistered and exempt from Securities Act registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.